Clinical Trials Browser

Phase 2 × Tomography, Optical Coherence × 90 days × Clear all

NCT05859334 2026-06-02

Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment

Phase 2 Recruiting

Glioma